Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

AIMS: Atrial fibrillation (AF) patients with contraindications to oral anticoagulation have had few options for stroke prevention. Recently, a novel oral anticoagulant, apixaban, and percutaneous left atrial appendage closure (LAAC) have emerged as safe and effective therapies for stroke risk reduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Vivek Y., Akehurst, Ronald L., Armstrong, Shannon O., Amorosi, Stacey L., Brereton, Nic, Hertz, Deanna S., Holmes, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927063/
https://www.ncbi.nlm.nih.gov/pubmed/26838691
http://dx.doi.org/10.1093/europace/euv412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927063/
https://www.ncbi.nlm.nih.gov/pubmed/26838691
http://dx.doi.org/10.1093/europace/euv412

Ejemplares similares